Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 356

1.

Assessing likelihood of product use for snus with modified-risk information among adult current cigarette smokers, former tobacco users, and never tobacco users.

Gerlach K, Shiffman S, Battista D, Polster M, Curtin G.

Addict Behav Rep. 2019 Jul 26;10:100208. doi: 10.1016/j.abrep.2019.100208. eCollection 2019 Dec.

2.

How intensely nondaily smokers smoke in laboratory topography sessions correlates with cigarette smoking intensity in the field.

Shiffman S, Scholl SM.

Exp Clin Psychopharmacol. 2019 Aug 8. doi: 10.1037/pha0000319. [Epub ahead of print]

PMID:
31393144
3.

Using nicotine gum to assist non-daily smokers in quitting: A randomized clinical trial.

Shiffman S, Scholl SM, Mao J, Ferguson SG, Hedeker D, Primack B, Tindle HA.

Nicotine Tob Res. 2019 May 24. pii: ntz090. doi: 10.1093/ntr/ntz090. [Epub ahead of print]

PMID:
31125988
4.

Very-low-nicotine-content cigarettes and dependence among non-daily smokers.

Shiffman S, Scholl SM, Mao JM.

Drug Alcohol Depend. 2019 Apr 1;197:1-7. doi: 10.1016/j.drugalcdep.2018.12.021. Epub 2019 Jan 31.

PMID:
30743194
5.

Five-year trends in acetaminophen use exceeding the recommended daily maximum dose.

Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S.

Br J Clin Pharmacol. 2019 May;85(5):1028-1034. doi: 10.1111/bcp.13894. Epub 2019 Mar 18.

PMID:
30740763
6.

Why we work with the tobacco industry.

Hughes JR, Fagerstrom KO, Henningfield JE, Rodu B, Rose JE, Shiffman S.

Addiction. 2019 Feb;114(2):374-375. doi: 10.1111/add.14461. Epub 2018 Nov 16. No abstract available.

PMID:
30324665
7.

Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes?

Shiffman S, Mao JM, Kurland BF, Scholl SM.

Psychopharmacology (Berl). 2018 Dec;235(12):3435-3441. doi: 10.1007/s00213-018-5056-8. Epub 2018 Oct 5.

PMID:
30291402
8.

An automated mapping method for Nissl-stained mouse brain histologic sections.

Shiffman S, Basak S, Kozlowski C, Fuji RN.

J Neurosci Methods. 2018 Oct 1;308:219-227. doi: 10.1016/j.jneumeth.2018.08.005. Epub 2018 Aug 7.

PMID:
30096343
9.

A latent state-trait model for analyzing states, traits, situations, method effects, and their interactions.

Hintz F, Geiser C, Shiffman S.

J Pers. 2019 Jun;87(3):434-454. doi: 10.1111/jopy.12400. Epub 2018 Aug 10.

PMID:
30095167
10.

Knowledge of dosing directions among current users of acetaminophen-containing medications.

Kelly JP, Battista DR, Shiffman S, Malone MK, Weinstein RB, Kaufman DW.

J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):492-498. doi: 10.1016/j.japh.2018.06.012. Epub 2018 Jul 21.

PMID:
30041852
11.

Exceeding the maximum daily dose of acetaminophen with use of different single-ingredient OTC formulations.

Shiffman S, Battista DR, Kelly JP, Malone MK, Weinstein RB, Kaufman DW.

J Am Pharm Assoc (2003). 2018 Sep - Oct;58(5):499-504. doi: 10.1016/j.japh.2018.05.012. Epub 2018 Jul 17.

PMID:
30030041
12.

People can change: Measuring individual variability in rehabilitation science.

Terhorst L, Juengst SB, Beck KB, Shiffman S.

Rehabil Psychol. 2018 Aug;63(3):468-473. doi: 10.1037/rep0000214. Epub 2018 Jul 19. Review.

PMID:
30024206
13.

Psychometric Evaluation of the Relapse Situation Efficacy Questionnaire in a Weight Loss Treatment Study.

Yu Y, Shiffman S, Rohay JM, Ma Q, Sereika SM, Sun R, Burke LE.

Am J Health Behav. 2018 Jul 1;42(4):80-89. doi: 10.5993/AJHB.42.4.8.

PMID:
29973313
14.

Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial.

Shiffman S, Kurland BF, Scholl SM, Mao JM.

JAMA Psychiatry. 2018 Oct 1;75(10):995-1002. doi: 10.1001/jamapsychiatry.2018.1831.

15.

Interaction between ethnicity and smoker type with dependence: A comparison of daily and intermittent African American and Caucasian smokers.

Cheng J, Shiffman S, King W, Scholl S.

Psychol Addict Behav. 2018 Jun;32(4):410-414. doi: 10.1037/adb0000375. Epub 2018 May 31.

16.

Time-varying copula models for longitudinal data.

Kürüm E, Hughes J, Li R, Shiffman S.

Stat Interface. 2018;11(2):203-221. doi: 10.4310/SII.2018.v11.n2.a1.

17.

Prevalence of exceeding maximum daily dose of paracetamol, and seasonal variations in cold-flu season.

Shiffman S, Battista DR, Kelly JP, Malone MK, Weinstein RB, Kaufman DW.

Br J Clin Pharmacol. 2018 Jun;84(6):1250-1257. doi: 10.1111/bcp.13551. Epub 2018 Mar 25.

18.

RE: Effectiveness of Pharmaceutical Smoking Cessation Aids in a Nationally Representative Cohort of American Smokers.

Shiffman S, Gitchell JG.

J Natl Cancer Inst. 2018 Oct 1;110(10):1141. doi: 10.1093/jnci/djy025. No abstract available.

19.

Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.

Nelson PR, Chen P, Battista DR, Pillitteri JL, Shiffman S.

Nicotine Tob Res. 2019 Jan 1;21(1):88-94. doi: 10.1093/ntr/nty011.

20.

Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users.

Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):322-331. doi: 10.1002/pds.4391. Epub 2018 Jan 26.

PMID:
29372579
21.

Three approaches to quantifying cigarette consumption: Data from nondaily smokers.

Shiffman S, Scholl SM.

Psychol Addict Behav. 2018 Mar;32(2):249-254. doi: 10.1037/adb0000346. Epub 2018 Jan 25.

PMID:
29369671
22.

Exposure to workplace smoking bans and continuity of daily smoking patterns on workdays and weekends.

Dunbar MS, Shiffman S, Chandra S.

Addict Behav. 2018 May;80:53-58. doi: 10.1016/j.addbeh.2018.01.006. Epub 2018 Jan 6.

23.

Momentary smoking context as a mediator of the relationship between SES and smoking.

Jahnel T, Ferguson SG, Shiffman S, Thrul J, Schüz B.

Addict Behav. 2018 Aug;83:136-141. doi: 10.1016/j.addbeh.2017.12.014. Epub 2017 Dec 15.

24.

Increases in Cigarette Consumption and Decreases in Smoking Intensity When Nondaily Smokers Are Provided With Free Cigarettes.

Shiffman S, Scholl S.

Nicotine Tob Res. 2018 Sep 4;20(10):1237-1242. doi: 10.1093/ntr/ntx221.

25.

Intermittent and daily smokers' subjective responses to smoking.

Shiffman S, Terhorst L.

Psychopharmacology (Berl). 2017 Oct;234(19):2911-2917. doi: 10.1007/s00213-017-4682-x. Epub 2017 Jul 18.

26.

Proximity and gravity: modeling heaped self-reports.

Allen CM, Griffith SD, Shiffman S, Heitjan DF.

Stat Med. 2017 Sep 10;36(20):3200-3215. doi: 10.1002/sim.7327. Epub 2017 May 11.

PMID:
28497551
27.

Day-to-Day Variability in Self-Reported Cigarettes Per Day.

Hughes JR, Shiffman S, Naud S, Peters EN.

Nicotine Tob Res. 2017 Sep 1;19(9):1107-1111. doi: 10.1093/ntr/ntx057.

28.

Ecological Momentary Assessment in Behavioral Research: Addressing Technological and Human Participant Challenges.

Burke LE, Shiffman S, Music E, Styn MA, Kriska A, Smailagic A, Siewiorek D, Ewing LJ, Chasens E, French B, Mancino J, Mendez D, Strollo P, Rathbun SL.

J Med Internet Res. 2017 Mar 15;19(3):e77. doi: 10.2196/jmir.7138.

29.

Classifying smoking urges via machine learning.

Dumortier A, Beckjord E, Shiffman S, Sejdić E.

Comput Methods Programs Biomed. 2016 Dec;137:203-213. doi: 10.1016/j.cmpb.2016.09.016. Epub 2016 Sep 23.

30.

Hierarchical Linear Modeling for Analysis of Ecological Momentary Assessment Data in Physical Medicine and Rehabilitation Research.

Terhorst L, Beck KB, McKeon AB, Graham KM, Ye F, Shiffman S.

Am J Phys Med Rehabil. 2017 Aug;96(8):596-599. doi: 10.1097/PHM.0000000000000690.

PMID:
28092277
31.

Association between smoking-related attentional bias and craving measured in the clinic and in the natural environment.

Begh R, Smith M, Ferguson SG, Shiffman S, Munafò MR, Aveyard P.

Psychol Addict Behav. 2016 Dec;30(8):868-875. doi: 10.1037/adb0000231.

PMID:
28068112
32.

Trends in serious quit attempts in the United States, 2009-14.

Gitchell JG, Shiffman S, Sembower MA.

Addiction. 2017 May;112(5):897-900. doi: 10.1111/add.13712. Epub 2017 Jan 26.

PMID:
27933678
33.

Cigarette smoking and ADHD: An examination of prognostically relevant smoking behaviors among adolescents and young adults.

Rhodes JD, Pelham WE, Gnagy EM, Shiffman S, Derefinko KJ, Molina BS.

Psychol Addict Behav. 2016 Aug;30(5):588-600.

34.
35.

Spatio-temporal determinants of mental health and well-being: advances in geographically-explicit ecological momentary assessment (GEMA).

Kirchner TR, Shiffman S.

Soc Psychiatry Psychiatr Epidemiol. 2016 Sep;51(9):1211-23. doi: 10.1007/s00127-016-1277-5. Epub 2016 Aug 24. Review.

36.

Using Multigroup-Multiphase Latent State-Trait Models to Study Treatment-Induced Changes in Intra-Individual State Variability: An Application to Smokers' Affect.

Geiser C, Griffin D, Shiffman S.

Front Psychol. 2016 Jul 22;7:1043. doi: 10.3389/fpsyg.2016.01043. eCollection 2016.

37.

An acetaminophen icon helps reduce medication decision errors in an experimental setting.

Shiffman S, Cotton H, Jessurun C, Rohay JM, Sembower MA.

J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):495-503.e4. doi: 10.1016/j.japh.2016.04.560. Epub 2016 Jul 27.

PMID:
27475837
38.

Repeated measures latent class analysis of daily smoking in three smoking cessation studies.

McCarthy DE, Ebssa L, Witkiewitz K, Shiffman S.

Drug Alcohol Depend. 2016 Aug 1;165:132-42. doi: 10.1016/j.drugalcdep.2016.05.025. Epub 2016 Jun 6.

39.

A cost-effectiveness analysis of over-the-counter statins.

Stomberg C, Albaugh M, Shiffman S, Sood N.

Am J Manag Care. 2016 May 1;22(5):e294-303.

40.

Public health implications of waterpipe tobacco use in the United States warrant initial steps towards assessing dependence.

Sidani JE, Shensa A, Shiffman S, Switzer GE, Primack BA.

Addiction. 2016 May;111(5):937-8. doi: 10.1111/add.13316. Epub 2016 Mar 14. No abstract available.

41.

Testing of Candidate Icons to Identify Acetaminophen-Containing Medicines.

Shiffman S, Cotton H, Jessurun C, Sembower MA, Pype S, Phillips J.

Pharmacy (Basel). 2016 Jan 27;4(1). pii: E10. doi: 10.3390/pharmacy4010010.

42.

Higher stimulus control is associated with less cigarette intake in daily smokers.

Ferguson SG, Shiffman S, Dunbar M, Schüz N.

Psychol Addict Behav. 2016 Mar;30(2):229-37. doi: 10.1037/adb0000149. Epub 2016 Jan 14.

43.

Relation of Health Literacy to Exceeding the Labeled Maximum Daily Dose of Acetaminophen.

Kaufman DW, Kelly JP, Battista DR, Malone MK, Weinstein RB, Shiffman S.

Am J Prev Med. 2016 Jun;50(6):e183-e190. doi: 10.1016/j.amepre.2015.11.005. Epub 2015 Dec 11.

PMID:
26689980
44.

Microrandomized trials: An experimental design for developing just-in-time adaptive interventions.

Klasnja P, Hekler EB, Shiffman S, Boruvka A, Almirall D, Tewari A, Murphy SA.

Health Psychol. 2015 Dec;34S:1220-8. doi: 10.1037/hea0000305.

45.

Development and psychometric properties of the Smoking Restraint Questionnaire.

Blake GA, Ferguson SG, Palmer MA, Shiffman S.

Psychol Addict Behav. 2016 Mar;30(2):238-45. doi: 10.1037/adb0000134. Epub 2015 Nov 9.

46.

Pharmacist and Physician Interpretation of Abbreviations for Acetaminophen Intended for Use in a Consumer Icon.

Shiffman S, Cotton H, Jessurun C, Sembower MA, Pype S, Phillips J.

Pharmacy (Basel). 2015 Oct 15;3(4):169-181. doi: 10.3390/pharmacy3040169.

47.

Behavioral associations with waterpipe tobacco smoking dependence among US young adults.

Sidani JE, Shensa A, Shiffman S, Switzer GE, Primack BA.

Addiction. 2016 Feb;111(2):351-9. doi: 10.1111/add.13163. Epub 2015 Oct 29.

48.

Mixed effects models for recurrent events data with partially observed time-varying covariates: Ecological momentary assessment of smoking.

Rathbun SL, Shiffman S.

Biometrics. 2016 Mar;72(1):46-55. doi: 10.1111/biom.12416. Epub 2015 Sep 27.

49.

Modeling intensive longitudinal data with mixtures of nonparametric trajectories and time-varying effects.

Dziak JJ, Li R, Tan X, Shiffman S, Shiyko MP.

Psychol Methods. 2015 Dec;20(4):444-69. doi: 10.1037/met0000048. Epub 2015 Sep 21.

50.

Commentary on McCarthy et al. (2015): Ecological momentary assessment--Reactivity? Intervention?

Shiffman S.

Addiction. 2015 Oct;110(10):1561-2. doi: 10.1111/add.13050. No abstract available.

PMID:
26350709

Supplemental Content

Loading ...
Support Center